Chicago Capital Management adds HeartWare International Inc (HTWR) to its portfolio

HeartWare International Inc (HTWR) : Chicago Capital Management added new position in HeartWare International Inc during the most recent quarter end. The investment management firm now holds 280,097 shares of HeartWare International Inc which is valued at $16,189,607 , the company said in a statement filed on Jul 15, 2016 with the SEC.HeartWare International Inc makes up approximately 5.86% of Chicago Capital Management’s portfolio.

Other Hedge Funds, Including , Nisa Investment Advisors sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 200 shares of HTWR which is valued $11,560. Havens Advisors added HTWR to its portfolio by purchasing 31,000 company shares during the most recent quarter which is valued at $1,786,840. HeartWare International Inc makes up approx 1.56% of Havens Advisors’s portfolio.Cutler Group Lp boosted its stake in HTWR in the latest quarter, The investment management firm added 19,869 additional shares and now holds a total of 41,410 shares of HeartWare International Inc which is valued at $2,386,872. HeartWare International Inc makes up approx 0.16% of Cutler Group Lp’s portfolio. Mazama Capital Management Inc added HTWR to its portfolio by purchasing 458 company shares during the most recent quarter which is valued at $26,399. HeartWare International Inc makes up approx 0.01% of Mazama Capital Management Inc’s portfolio. Bnp Paribas Arbitrage Sa added HTWR to its portfolio by purchasing 711 company shares during the most recent quarter which is valued at $40,982.

HeartWare International Inc opened for trading at $57.65 and hit $57.8 on the upside on Monday, eventually ending the session at $57.8, with a gain of 0.36% or 0.21 points. The heightened volatility saw the trading volume jump to 1,99,883 shares. Company has a market cap of $1,014 M.

On the company’s financial health, HeartWare International Inc reported $-0.95 EPS for the quarter, missing the analyst consensus estimate by $ -0.22 based on the information available during the earnings call on May 4, 2016. Analyst had a consensus of $-0.73. The company had revenue of $55.10 million for the quarter, compared to analysts expectations of $60.20 million. The company’s revenue was down -21.3 % compared to the same quarter last year.

Many Wall Street Analysts have commented on HeartWare International Inc. HeartWare International Inc was Downgraded by Raymond James to ” Mkt Perform” on Jul 13, 2016. HeartWare International Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 11, 2016. HeartWare International Inc was Downgraded by Wells Fargo to ” Market Perform” on Jun 29, 2016.

Heartware International Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System) which includes a ventricular assist device (VAD) or blood pump patient accessories and surgical tools provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart avoiding abdominal surgery directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller which circulates a cushion of blood.

Leave a Reply

HeartWare International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on HeartWare International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.